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Growth in children with chronic renal failure on conservative treat-
ment. Statural growth and its relationship with degree of renal insuffi-
ciency were studied in 42 children and 5 infants with chronic renal fail-
ure (CRF). Most of the children had a congenital disease or were al-
ready ill in the neonatal period. Average GFR was 34 ml/min/l.73 m2
at the beginning and 16 ml at the end of the follow-up period, which
averaged 4.3 years (Ito 12 years). Most patients grew at a normal rate;
only 3 out of 42 children (7%) and 3 out of 5 infants lost one standard
deviation or more during the follow-up period. No correlation was
found between the degree of GFR and growth velocity. Catch-up
growth was observed only for a 12-month period in 4 children with a
bone age of 7 to 8 years. In 10 Out of 11 children who reached puberty
while under observation, a normal pubertal growth spurt was ob-
served. Suitable and comprehensive controls and treatment can arrest
growth retardation in the great majority of children with CRF after the
first few years of life, regardless of their GFR. Achievement of a nor-
mal growth pattern in infants with CRF during the first year(s) of life
remains a major unsolved problem.
La croissance chèz les enfants en insuflisance renale chronique en traite-
ment conservateur. La croissance staturale et sa relation avec le dgré
d'insuffisance rénale ont été étudiées chêz 42 enfants et 5 nourrissons
en insuffisance renale chronique (IRC). Presque tous avaient une
maladie rénale présente des la naissance ou étaient malades des Ia
période néonatale. La filtration glomerulaire moyenne (FG) était de 34
ml/min/1.73 m2 au debut et 16 ml a la fin de Ia période d'observation
qui était, en moyenne, de 4.3 ans (1 a 12 ans). La grande majorité des
enfants a grandi avec une vitesse de croissance normale; seulement 3
des 42 enfants (7%) et 3 nourrissons sur 5 ont perdu au moms une
deviation standard pendant Ia pCriode d'observation. Aucune
correlation n'a été retrouvée entre le degré de I'IRC et Ia vitesse de
croissance. Une courbe de rattrappage a été observée chèz 4 enfants
avec un age osseux de 7 a 8 ans et pendant une période de 12 mois
seulement. Onze enfants ont atteint leur puberte; chéz 10 d'entre eux
une acceleration pubertaire normale de Ia croissance a été observée.
Le traitement conservateur adapté sur des contrôles appropriés peut
arrêter le retard de croissance dans Ia grande majorité des enfants en
IRC independamment du degre de leur FG. Obtenir une croissance
normale chèz le nourrisson en IRC reste un problème important et non
encore resolu.
Growth retardation is a well-known consequence of chronic
renal failure (CRF) in children [1—61. At present, dialysis and
transplantation only rarely lead to catch-up growth and the
subsequent hope of normalizing a compromised statural situ-
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ation; consequently, the problem of growth during the phase of
conservative treatment is extremely important. We report the
results of a study that evaluated growth on the basis of chrono-
logic and bone age in children with CRF on conservative treat-
ment, as well as the correlation between growth velocity and
the degree of renal insufficiency.
Methods
The study was based on 42 children (13 females and 29
males) ranging in age from 1 to 15 years (mean age, 6.7 years)
and 5 infants who were first observed during their first 6
months of age, when first seen in this Department. All the
patients fulfilled the following criteria: (1) a GFR persistently
less than 70 ml/min/1.73 m2; (2) at least one determination of
bone age available; (3) a minimum follow-up of one year, and
(4) no important proteinuria, or nephrotic syndrome, or ster-
oid treatment.
Laboratory studies of blood samples were carried out at least
every 6 months in most patients, including determinations of
serum bicarbonate, phosphorus, alkaline phosphatase, PTH,
sodium, potassium, and chloride. GFR was regularly evalu-
ated by creatinine clearance and, occasionally, by '311-io-
thalamate clearance. Pharmacologic and dietary treatment
were based and constantly adjusted on the results of the inves-
tigations of interviews with the dietitian, and of alimentary in-
take records when available.
Height was measured with a stadiometer while the children
under 2 were in the recumbent position and the children over
2 were in the standing position. Height was assessed at least
twice a year in most of the children, and centiles for height and
growth velocity were plotted from the charts of Tanner and
Whitehouse [71. The five infants had a special protocol, which
included monthly biochemical controls, height and weight de-
terminations, clinical examinations, and alimentary intake rec-
ords covering a 7-day period with interviews by the dietitian;
in addition, the parents of these children had other informal
contacts with dietitians and social workers, when needed. Pre-
scribed calorie intake was 120% of RDA [291 in the 5 infants;
prescribed protein intake varied from 100% to 60% of RDA, ac-
cording to their GFR levels.
Bone age was always assessed by the same observer at least
once every 12 months, according to the TW2 method [8]; re-
producibility of results was  0.2 years. Because bone age in
the 5 infants could not be precisely measured, and in 6 chil-
dren it had been assessed only once or twice, these 10 chil-
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Males Females Total
Posterior urethral valves 23 0 23
Renal hypoplasia + dysplasia 3 1 4
Reflux nephropathy 0 5 5
Neonatal asphyxia 3 0 3
Nephronophtisis 2 1 3
Polycystic disease 1 2 3
Hemolytic uremic syndrome 0 2 2
Methyl malonic acidosis 0 2 2
Distal tubular acidosis 1 0 1
Juvenile cystinosis 1 0 1
dren (9 males and I female) are not included in the figures and
in the results of growth according to bone age. Standard de-
viation (SD) score values were determined according to Tanner
9J. Growth velocity was calculated over a 12-month period
and, when bone age values were available, approximately in
the middle of this period.
If not otherwise indicated, age is expressed in tenths of a
year. Catch-up growth was defined as growth velocity in at
least a one year period over the 97th percentile referred to bone
age.
Results
Clinical diagnoses in the 42 children and 5 infants are re-
ported in Table 1. Except for 2 children with hemolytic uremic
syndrome, all had congenital disease or were already ill in the
neonatal period. The average GFR in the 42 children was 34
ml/min/l.73 m2 (9 to 70 ml) at the beginning and 16 ml (4 to 42
ml) at the end of the follow-up period, which ranged from I to
12 years with an average of 4.3 years.
Average height at first presentation was — 1.57 SD (— 1 .59 in
boys, — 1.53 in girls), and at the end of the follow-up it was
—1.49 SD (—1.66 in boys, —1.05 in girls); most children grew
at a normal rate and remained in their respective centiles until
puberty, when a gain in centiles wa evident in a few of them
(Figs. 1 and 2). Least growth was observed in a boy first seen
at 11 years of age with a severe osteodystrophy, slipped
epiphysis, and bone deformities.
Three male infants were followed from the age of 1 month,
and two from the age of 2 and 6 months, respectively (Fig. 1).
Their initial GFRs ranged from 4 to 21 ml/min/l.73 m2 (mean,
14 ml); and their final GFRs, from 7 to 33 (mean, 18 ml). Only
2 did not show a significant loss in height after the first obser-
vation. Both had a GFR of 14 ml/min/l.73 m2, and a plasma
creatinine concentration of 2.2 and 1.8 mg/dl, respectively, at
first presentation. The other 3 infants, who grew at an ab-
normal rate, had an initial GFR of 4, 20, and 16 mI/min/1.73 m2,
respectively. It is worth noting that one already had a stature
of —2.9 SD when first seen at 6 months of age. Because his
birth height was reported as being normal, he had lost almost
0.5 SD per month. Another infant, whose stature at the end of
the follow-up was —2.4 SD, lost his growth potential mostly
during the first 4 months of life (—0.6 SD per month).
Growth is normally very rapid in this period, and in order to
see if the growth rate in our 5 infants correlated with their ali-
mentary intake, we identified the periods of poor and those of
satisfactory growth and asked the dietitian to quantify, blindly,
Age, years
Fig. 2. Growth curves inferno/es according to the chronologic age.
the average calorie intake during each of these periods of time.
Twelve periods during which growth velocity was constant
were identified, each period lasting, on average, 9.4 months (3
to 24 months). The growth rates, expressed as a percent of nor-
mal growth for children of the same age growing at the 50th
Table 1. Primary diseases in the 47 children with chronic renal failure
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Fig. 1. Growth curves in males according to the chrono/ogic age.
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Fig. 3. Correlation in 5 infants between the growth rates, expressed as
a percent of normal growth, and average calorie intake expressed as
percent of RDA during 12 periods of constant growth velocity.
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Fig. 4. Growth curves in males according to the bone age.
percentile, were calculated for each period (the expected
growth in the three shortest periods, of 3 months, was 8 to 10
cm) and plotted against the average calorie intake, expressed
as percentage of RDA (Fig. 3). Growth in periods of calorie in-
take 100% RDA averaged 53% (10% to 72%) of that ex-
pected, whereas it averaged 97% (61% to 130%) during periods
with a calorie intake > 100% RDA. Growth curves according
to bone age paralleled chronologic age curves, but most fell
above the 3rd centile (Figs. 4 and 5). As a matter of fact, av-
erage SD scores for heights according to bone and chronologic
Start End
Boys 0.42 0.49
Girls —0.25 0.08
All 0.21 0.38
Variationa
lmpr
no.
oved
%
Stable
no. %
Wors
no.
ened
%
0.5 SD
ByCA 13 28 26 55 8 17
ByBA 14 38 16 43 7 19
1 SD
ByCA 7 15 34 72 6 13
ByBA 11 30 24 65 2 5
a CA and BA refer to whether the SD scores were calculated
according to the chronologic age (CA) or calculated according to the
bone age (BA).
age at the start and at the end of the follow-up changed very
little (Table 2).
The average differences between bone and chronologic age
at the beginning and at the end of the follow-up were —0.49
years (—4.1 to + 1.9 years) and —0.42 years (—4.1 to +3.0
years), respectively. For boys, this difference was —0.89 years
and 0.54 years, and for girls it was + 0.15 and + 0.12 years, re-
spectively. Table 3 reports overall growth according to chrono-
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Fig. 5. Growth curves in females according to the bone age.
Table 2. Differences in average SD scores for heights according to
bone age vs. SD scores according to chronologic age, at the start and
at the end of the follow-up
100
50
Table 3. Growth expressed in SD scores according to chronologic and
bone age considering 0.5 SD and SD as an arbitrary variation
during the follow-up period
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Bone age, years
Fig. 6. Growth velocity in boys with various degrees of glomerular fil-
tration rate.
logic and bone age expressed in SD scores, considering  0.5
and  1 SD as an arbitrary variation during the follow-up pe-
riod. Seven children (15%) gained, and six (13%) lost at least
one SD when chronologic age is considered; 30% improved,
and only 5% worsened if growth is correlated with bone age.
Only 3 out of 42 children (7%) lost at least one SD, but 3 out of
5 infants lost between 1.3 and 2.4 SD during follow-up.
Growth velocity according to the bone age and its relation-
ship with different degrees of GFR are shown in Figs. 6 and 7.
As might have been expected from the preceding figures,
growth velocity appears within normal range in most of the
children. Moreover, no relationship between the degree of
GFR and growth velocity is evident. The same conclusion is
drawn when SD scores of height on the first visit are plotted
against GFR of that time (0.20 > P > 0.15). In fact, almost all
children with a growth velocity under the 3rd percentile had a
GFR over 10 ml/min/l .73 m2. It is also worth adding that in all
other periods with a GFR less than 10 ml, growth velocity was
consistently within normal limits.
Catch-up growth, that is, growth velocity over the 97th cen-
tile, was observed only in 4 children with a bone age of 7 to 8
years, and only for a 12-month period. Their statural gain, on
this occasion, was 8 to 9 cm per year.
A comparison between growth rate during the first and sec-
ond years of follow-up was performed in 35 children (infants
and pubertal children were excluded). Growth rate averaged
94.4% of normal during the first year and 93.7% in the second
year of care.
Eleven children, five boys and six girls, reached puberty ac-
cording to their bone age. In all but one, a pubertal growth
spurt within normal limits was recorded even though GFR was
constantly less than 30 ml in 5 boys and 1 girl (Figs. 6 and 7).
Bone age, years
Fig. 7. Growth velocity in girls with various degrees of glomerular fil-
tration rate.
The average chronologic age at the apex of pubertal growth
spurt was 13.5 years (11 to 16 years) for boys and 12.6 years
(11.5 to 13,7 years) for girls.
The great majority of the parents of our children had several
interviews with the dietitian. On the average, every family had
four interviews a year. Sufficiently regular dietary records of
one week's duration were available in 16 children (infants not
included), principally those with GFRs less than 20 mllmin/l .73
m2. On the average, we obtained six dietary records per pa-
tient. The average calorie intake in these 16 children was 108%
RDA (79% to 161%). In 7 children, calorie supplementation
was given for a varying period of time (3 months to 6 years).
Discussion
The final height in children with CRF depends on the gain or
loss of growth potential during the periods of conservative
treatment and chronic dialysis, and after renal transplantation.
Data from the EDTA clearly show that most children are al-
ready small when they enter a dialysis program [10], and sub-
sequent growth on hemodialysis [1, 10, 11] or on CAPD [12—14]
is far from satisfactory. Growth is better after transplantation,
but catch-up growth is rarely recorded [1, 3, 15].
Very recently, Chantler et al [16] reported that in long-term
survivors of treatment for end-stage renal failure the average
statural situation at the end of follow-up was worse than it was
at the beginning in both prepubertal and pubertal children.
Therefore, the essential condition for providing a child with
CRF a good chance of reaching a satisfactory adult height, is
to start dialysis and transplantation programs with a height
within normal limits. It follows that the period of conservative
treatment is crucial for obtaining this goal.
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Although it has been long demonstrated that CRF in chil-
dren is associated with poor growth [1—61, there are very few
long-term studies regarding growth during the period of con-
servative treatment [17—22], or the relationship between growth
and the degree of renal insufficiency [19]. Betts and Magrath
showed that growth potential was progressively lost with in-
creasing age, and in concomitance with a GFR reduction un-
der 25 ml/min/l.73 m2 [19].
Gilli et al [18] followed 17 children with varying degrees of
CRF for 1 to 5 years; 41% were under the 3rd percentile at the
start, and 53% were under this centile at the end of follow-up,
and the retardation in height for age then tended to increase
with time (no other details were given). In contrast, Mehls et
al [1] stated that "it is not unusual to see preschool children
with moderate renal insufficiency who are dwarfed but who
grow at a normal rate." Kleinknecht et al [20, 21] also re-
ported that the great majority of children with CRF grew at a
normal rate after first examination at their institution. Our
study, which also includes data on growth according to bone
age, confirms these findings, and extends a previous investi-
gation [22]. In 36% of children, height according to bone age
was already under the 3rd centile when they entered the study.
Whether this was due to a loss of height exclusively during in-
fancy or also to the absence of adequate therapy in subse-
quent years cannot be deduced from our data. Nevertheless, it
seems likely that both causes may be involved, at least in some
children. In most of our children, growth velocity was normal
during follow-up; 72% maintained the same SD, and 15% im-
proved by 1 SD or more. Growth is an extremely sensitive proc-
ess which is influenced by a variety of factors, and thus it is
impossible to state with certainty the causes of poor growth in
the 6 children who lost at least 1 SD during follow-up. How-
ever, it is noteworthy that 3 were infants who presented CRF
at birth; among the other 3, a child had a striking osteodys-
trophy with slipped epiphysis and another was lost to the fol-
low-up for 3 years.
That stunting of growth in CRF is more severe in infants has
already been shown [6]. In 14 infants seen before 6 months of
age, Kleinknecht, Broyer, and Huot [211 observed a mean
height of —2 SD, indicating an average loss of 0.4 SD per
month. In our experience as well, stunting growth was ob-
served mainly during the first few months of life in 2 of the 3
infants who did not show satisfactory growth.
A delay in skeletal maturity is a common feature in children
with chronic renal failure. Betts and Magrath [19] demon-
strated that bone age was delayed by more than one year in 15
out of 31 children, and that the delay was not correlated with
the chronologic age or the degree of renal failure. Our results
show that most of the children had a bone age delay that re-
mained more or less stable during follow-up; this fact indicates
that the retardation occurred mostly at an early age when
growth potential was lost, and that it was not necessarily pro-
gressive. The relationship between growth rate and the degree
of GFR has not been widely studied even if some workers be-
lieve that growth velocity seems influenced also by renal func-
tion [1, 18]. In children with a GFR over 25 ml, Betts and
Magrath [19] found a growth rate within 90% of that normally
expected; under this level, 55% of the children had a growth
rate within 75% of the expected rate for their age. Because
these investigators report that the appearance of osteodys-
trophy accompanied the GFR reduction, it seems impossible to
be sure that the reduction in growth velocity is due only to the
decline in renal function. In agreement with Kleinknecht,
Broyer, and Huot [21] and with our previous findings [22], the
present study demonstrates that growth velocity is not corre-
lated with the degree of renal insufficiency, and that other
causes of stunting growth must be considered.
Very few reports treat the frequency of catch-up growth in
children with CRF. Gilli et all [18] did not observe any catch-
up growth in 17 children with renal insufficiency under obser-
vation from 1 to 5 years, and Kleinknecht et al [20] reported
catch-up growth in only 2 out of 19 patients. We observed
catch-up growth in only 4 children, and its duration was only 1
year. The fact that this occurred in 3 patients during the first
year of follow-up indicates that the correction of metabolic dis-
turbances accompanied by careful dietary assistance may lead
to a temporary restoration of the growth potential, at least in a
few cases. That in the great majority of children a poorer
growth rate should not be expected during the 2nd year of care
compared with the 1st year has also been demonstrated by our
study.
Catch-up growth was demonstrated in 5 children with se-
vere CRF treated with 1,25-dihydroxyvitamin D3 [23], but the
same results have not been reported in children with moderate
CRF after 1 year of treatment with 25-hydroxyvitamin D3 [24].
None of our children received 1,25-dihydroxyvitamin D3, and
only a few were treated with 25-hydroxyvitamin D3; most had
been treated very early with suitable doses of vitamin D3. Why
catch-up growth is so rare in children with CRF is not known.
It has been suggested that an accelerated growth rate is pre-
vented by the presence of uremic toxins, or an inadequate cor-
rection of all metabolic disturbances, or early uremia-induced
damage of cartilage [25]. Normal growth but absence of catch-
up of the growth retardation has also been reported in experi-
mental uremia [31].
The possibility for a child with CRF to present a pubertal
growth spurt has been little investigated. Gilli et al [18] ob-
served a pubertal spurt in only I of 17 children followed lon-
gitudinally, but the ages of the children are not given. Klein-
knecht et al [21] reported that 5 children had a normal pubertal
spurt despite a GFR under 12 ml/min/l.73 m2. The present
study confirms these data and extends preliminary findings [22]
that a normal pubertal growth spurt can be obtained in the ma-
jority of children with CRF regardless of their GFR degree, and
that the onset of the pubertal growth spurt is closely related to
bone age, as seen in normal children [26]. Our results and those
of others show that suitable and comprehensive controls, early
correction of acidosis and hydroelectrolytic disturbances, the
early use of vitamin D in doses tailored to the biochemical and
hormonal results and to radiologic controls, and the constant
dietary assistance can arrest growth retardation in the great
majority of children with CRF after the first few years of life
regardless of their GFR. Particularly, careful and frequent
clinical, biochemical, and dietary controls must therefore be
planned in children who loose growth potential after this age,
whatever the degree of their renal function.
The importance of a normal energy intake had been stressed
very recently by Arnold, Danford, and Holliday [30], who dem-
onstrated that children 2.5 to 11 years old with poor growth and
renal insufficiency who were ingesting less than 75% RDA cab-
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ries experienced improved growth with caloric supplementa-
tion [30]. The results of diet records in 16 of our children over
age 2 are consistent with the conclusions of Arnold, Danforth,
and Holliday [301. As a matter of fact, energy intake in our pa-
tients, who grew at a normal rate, averaged 108% RDA and
ranged between 79% and 161%.
Achievement of a normal growth pattern in infants with CRF
during the first year, or years, of life remains a major unsolved
problem. It is well known that a number of specific disorders,
such as acidosis, hypostenuria, renal osteodystrophy, calorie
deficiency, and unresponsiveness to certain hormones, are as-
sociated with growth failure in children with chronic renal in-
sufficiency [2j. It is not known if one of these factors plays an
especially important role in infants with CRF, and it would be
very difficult to demonstrate. The present study suggests that
a reduced, inadequate calorie intake in our infants was consis-
tently concomitant with periods of stunting growth. Even if we
could not demonstrate any significant changes in any of the
other factors listed above during these periods, the possibility
that anorexia was a consequence of other undiscovered (non-
investigated) imbalances cannot be excluded. Nevertheless, re-
integration of the alimentary intake to the previously pre-
scribed levels, obtained in some instances also by continuous
enteral nutrition, led in most cases to restoration of the growth
curve but not to catch-up growth. In our infants, a calorie in-
take that fulfilled the RDA was not associated with normal
growth; our data suggest that in these patients calorie intake
should therefore exceed the RDA for healthy children. That ure-
mic subjects are more dependent on the level of calorie intake
than are normal individuals has already been suggested [27,
28].
It is our common experience that, in addition to the clinical
and biochemical disturbances, other factors of primary impor-
tance also affect the average daily alimentary intake, es-
pecially in infants and small children with CRF. These include
the distance from the hospital, the social and economical sit-
uation of the family, the number and the age of the other sib-
lings, the quality of the relationship and cooperation between
the medical staff and the family, and the ready availability of
the dietitians, doctors, and nurses. It is then not surprising that
the task of keeping these infants totally and constantly bal-
anced in all respects even when they are at home is very dif-
ficult. Because these infants can lose as much as 0.6 SD per
month as also shown by our study, it is evident that a delay of
a few months in the diagnosis or an incomplete control of the
biochemical and alimentary situation for only a few months
may lead to an irreversible loss of growth potential of as much
as 2 to 3 SD.
In conclusion, all efforts should be made to diagnose the
presence of CRF as early as possible to allow immediate and
comprehensive treatment, well tailored to careful and frequent
clinical, biochemical, and dietetical controls, especially in in-
fants and in children who seem to lose growth potential. The
degree of CRF itself should no longer be considered the rea-
son for poor growth, at least in the great majority of these chil-
dren. Because it is evident that the major growth problems in
children with CRF are encountered in infants, our attention
and our future clinical long-term follow-up studies should be di-
rected mainly to children of this age.
Reprint requests to Dr. G. Rizzoni, Clinica Pediatrica, Universith
degli Studi di Padova, Via Giustiniani, 3, 35128 Padova, Italy
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